{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T05:26:31Z","timestamp":1768281991438,"version":"3.49.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>To date, the treatment strategy and long-term prognosis of acute kidney injury (AKI) after taking Benikoji CholesteHelp<jats:sup>\u00ae<\/jats:sup>, a red yeast rice supplement, remains unclear. We present three cases wherein renal dysfunction improved within a few months of supplement discontinuation, without immunosuppressive therapy. Case 1: A 59-year-old woman with a history of hypertension, treated with telmisartan (serum creatinine [sCr]: 0.65\u00a0mg\/dL; estimated glomerular filtration rate [eGFR]: 71.3\u00a0mL\/min\/1.73\u00a0m<jats:sup>2<\/jats:sup>) and Benikoji CholesteHelp<jats:sup>\u00ae<\/jats:sup> for 7\u00a0months, developed Fanconi syndrome (FS) and severe renal impairment (sCr: 2.32\u00a0mg\/dL; eGFR: 17.7\u00a0mL\/min\/1.73\u00a0m<jats:sup>2<\/jats:sup>). Renal biopsy and gallium-67 scintigraphy revealed no active drug-induced interstitial nephritis. Her condition improved significantly after supplement discontinuation. Her renal function gradually improved, with 3-month follow-up sCr and eGFR values of 0.96\u00a0mg\/dL and 46.5\u00a0mL\/min\/1.73\u00a0m<jats:sup>2<\/jats:sup>, respectively; however, these were still worse than the pre-onset values. Case 2: A 48-year-old man had mild renal dysfunction (sCr: 1.12\u00a0mg\/dL; eGFR: 56.76\u00a0mL\/min\/1.73\u00a0m<jats:sup>2<\/jats:sup>) after taking Benikoji CholesteHelp<jats:sup>\u00ae<\/jats:sup> for approximately 2\u00a0years; this was reversed upon supplement discontinuation. Case 3: A 47-year-old man with FS and mild renal dysfunction (sCr: 1.09\u00a0mg\/dL; eGFR: 58.5\u00a0mL\/min\/1.73\u00a0m<jats:sup>2<\/jats:sup>) after taking Benikoji CholesteHelp<jats:sup>\u00ae<\/jats:sup> for approximately 4\u00a0months, showed notable improvement in FS after supplement discontinuation; however, the mild renal dysfunction persisted. The primary intervention in all cases was immediate supplement discontinuation, leading to rapid improvement in renal function, without need for immunosuppressive therapy. These findings increase our understanding of renal impairment caused by red yeast rice, with improvement after withdrawal, sometimes after several months.<\/jats:p>","DOI":"10.1007\/s13730-024-00955-2","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T22:10:48Z","timestamp":1733955048000},"page":"468-476","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Fanconi syndrome following administration of oral supplements containing red yeast rice: several months follow-up of three cases"],"prefix":"10.1007","volume":"14","author":[{"given":"Reina","family":"Matsui-Hosoya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motohiro","family":"Yagasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitomi","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Fukao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Kano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9446-2390","authenticated-orcid":false,"given":"Hiroaki","family":"Io","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,11]]},"reference":[{"key":"955_CR1","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1111\/j.1523-1755.2004.00927.x","volume":"66","author":"RL Mehta","year":"2024","unstructured":"Mehta RL, Pascual MT, Soroko S, et al. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int. 2024;66:1613\u201321.","journal-title":"Kidney Int"},{"key":"955_CR2","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","volume":"41","author":"EAJ Hoste","year":"2015","unstructured":"Hoste EAJ, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41:1411\u201323.","journal-title":"Intensive Care Med"},{"key":"955_CR3","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1007\/s10157-015-1201-4","volume":"20","author":"H Yokoyama","year":"2016","unstructured":"Yokoyama H, Narita I, Sugiyama H, et al. Drug-induced kidney disease: a study of the Japan renal biopsy registry from 2007 to 2015. Clin Exp Nephrol. 2016;20:720\u201330.","journal-title":"Clin Exp Nephrol"},{"key":"955_CR4","first-page":"985","volume":"54","author":"T Takei","year":"2012","unstructured":"Takei T, Nitta K. Drug-induced nephrotoxicity with impaired renal function. Jpn J Nephrol. 2012;54:985\u201390.","journal-title":"Jpn J Nephrol"},{"key":"955_CR5","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/qjmed\/hct258","volume":"107","author":"AM Hall","year":"2014","unstructured":"Hall AM, Bass P, Unwin RJ. Drug-induced renal Fanconi syndrome. QJM. 2014;107:261\u20139.","journal-title":"QJM"},{"key":"955_CR6","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.fct.2016.07.024","volume":"107","author":"AC Brown","year":"2017","unstructured":"Brown AC. Kidney toxicity related to herbs and dietary supplements: online table of case reports. Part 3 of 5 series. Food Chem Toxicol. 2017;107:502\u201319.","journal-title":"Food Chem Toxicol"},{"key":"955_CR7","doi-asserted-by":"publisher","unstructured":"Maiguma M, Kihara M, Suzuki Y, et al. (2024) CEN Case Rep. 2024; https:\/\/doi.org\/10.1007\/s13730-024-00897-9. Online ahead of print","DOI":"10.1007\/s13730-024-00897-9"},{"key":"955_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s13730-024-00903-0","author":"K Oda","year":"2024","unstructured":"Oda K, Murata T, Tanaka F, et al. A case of acute kidney injury and Fanconi syndrome while taking multiple supplements, including red yeast rice cholesterol Help\u00ae. CEN Case Rep. 2024. https:\/\/doi.org\/10.1007\/s13730-024-00903-0.","journal-title":"CEN Case Rep"},{"key":"955_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/ckj\/sfae151","volume":"17","author":"R Miyazaki","year":"2024","unstructured":"Miyazaki R, Takahashi Y, Kawamura T, et al. Acute kidney tubular injury after ingestion of red yeast rice supplement. Clin Kidney J. 2024;17:151.","journal-title":"Clin Kidney J"},{"key":"955_CR10","first-page":"2824","volume":"9","author":"Y Murata","year":"2024","unstructured":"Murata Y, Hemmi S, Akiya Y, et al. Certain red yeast rice supplements in Japan cause acute tubulointerstitial injury. ISN. 2024;9:2824\u20138.","journal-title":"ISN"},{"key":"955_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000540258","volume":"14","author":"K Takeuchi","year":"2024","unstructured":"Takeuchi K, Kawamura S, Wada Y, et al. Renal impairment of proximal tubular injury caused by red yeast rice supplement: report of 2 cases. Case Rep Nephrol Dial. 2024;14:128\u201337.","journal-title":"Case Rep Nephrol Dial"},{"key":"955_CR12","doi-asserted-by":"publisher","first-page":"7259","DOI":"10.1038\/s41598-017-07718-3","volume":"7","author":"G Sennari","year":"2017","unstructured":"Sennari G, Saito R, Hirose T, et al. Antimalarial troponoids, puberulic acid and viticolins; divergent synthesis and structure-activity relationship studies. Sci Rep. 2017;7:7259.","journal-title":"Sci Rep"},{"key":"955_CR13","doi-asserted-by":"publisher","first-page":"3277","DOI":"10.1093\/ndt\/gfq152","volume":"25","author":"AI Joaquim","year":"2010","unstructured":"Joaquim AI, Mendes GEF, Ribeiro PFF, et al. Ga-67 scintigraphy in the differential diagnosis between acute interstitial nephritis and acute tubular necrosis: an experimental study. Nephrol Dial Transplant. 2010;25:3277\u201382.","journal-title":"Nephrol Dial Transplant"},{"key":"955_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/00005792-200005000-00002","volume":"79","author":"T Messiaen","year":"2000","unstructured":"Messiaen T, Deret S, Mougenot B, et al. Adult Fanconi syndrome secondary to light chain gammopathy. Clinicopathologic heterogeneity and unusual features in 11 patients. Medicine (Baltimore). 2000;79:135\u201354.","journal-title":"Medicine (Baltimore)"},{"key":"955_CR15","first-page":"278","volume":"35","author":"H Ren","year":"2008","unstructured":"Ren H, Wang WM, Chen XN, et al. Renal involvement and follow up of 130 patients with primary Sj\u00f6gren\u2019s syndrome. J Rheumatol. 2008;35:278\u201384.","journal-title":"J Rheumatol"},{"key":"955_CR16","unstructured":"Practice guidelines for drug-induced kidney disease 2016. Nihon Jinzo Gakkai Shi. 2016; 58:477\u2013555."},{"key":"955_CR17","first-page":"505","volume":"15","author":"K Joh","year":"1997","unstructured":"Joh K. Kanshitsuseijinen no byourishindan [Pathological diagnosis of interstitial nephritis]. Pathol Clin Med. 1997;15:505\u201319 ((in Japanese)).","journal-title":"Pathol Clin Med"},{"key":"955_CR18","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1093\/ndt\/gfq224","volume":"25","author":"S Grang\u00e9","year":"2010","unstructured":"Grang\u00e9 S, Bertrand DM, Guerrot D, et al. Acute renal failure and Fanconi syndrome due to deferasirox. Nephrol Dial Transplant. 2010;25:2376\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"955_CR19","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1046\/j.1365-2796.1999.00515.x","volume":"246","author":"E Andreev","year":"1999","unstructured":"Andreev E, Koopman M, Arisz L. A rise in plasma creatinine that is not a sign of renal failure: which drugs can be responsible? J Int Med. 1999;246:247\u201352.","journal-title":"J Int Med"},{"key":"955_CR20","first-page":"313","volume":"34","author":"M Klimek","year":"2009","unstructured":"Klimek M, Wang S, Ogunkanmi A. Safety and efficacy of red yeast rice (Monascus purpureus) as an alternative therapy for hyperlipidemia. P T. 2009;34:313\u201327.","journal-title":"P T"},{"key":"955_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-227961","volume":"12","author":"L Loubser","year":"2019","unstructured":"Loubser L, Weider KI, Drake SM. Acute liver injury induced by red yeast rice supplement. BMJ Case Rep. 2019;12: e227961.","journal-title":"BMJ Case Rep"},{"key":"955_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/molecules24101944","volume":"24","author":"J Song","year":"2019","unstructured":"Song J, Luo J, Ma Z, et al. Quality and authenticity control of functional red yeast rice-a review. Molecules. 2019;24:2\u201325.","journal-title":"Molecules"},{"key":"955_CR23","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1186\/s12864-020-06864-9","volume":"21","author":"Y Higa","year":"2020","unstructured":"Higa Y, Kim YS, Altaf-Ul-Amin M, et al. Divergence of metabolites in three phylogenetically close Monascus species (M. pilosus, M. ruber, and M. purpureus) based on secondary metabolite biosynthetic gene clusters. BMC Genomics. 2020;21:679.","journal-title":"BMC Genomics"},{"key":"955_CR24","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.nefro.2016.02.002","volume":"36","author":"JA Martin-Navarro","year":"2016","unstructured":"Martin-Navarro JA, Petkov-Stoyanova V, Gutierrez-Sancheza MJ, et al. Acute renal failure secondary to interstitial acute nephritis and Fanconi syndrome due to metamizole and gemfibrozil. Nefrologia. 2016;36:318\u201332.","journal-title":"Nefrologia"},{"key":"955_CR25","unstructured":"Kobayashi Pharmaceutical Co., Ltd. Request to discontinue use of red yeast rice-related products and notice of voluntary recall (2nd report)."}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-024-00955-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13730-024-00955-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-024-00955-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T15:01:35Z","timestamp":1748790095000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13730-024-00955-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,11]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["955"],"URL":"https:\/\/doi.org\/10.1007\/s13730-024-00955-2","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,11]]},"assertion":[{"value":"27 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving Human Participants and\/or Animals"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}